Chronic myeloid leukemia pediatric · 3 regimens
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Nilotinib monotherapy Variant #01 | — | R 27 206 | 28d | — | — | — | — | — |
Imatinib monotherapy Variant #17 | — | R 27 014 | 30d | ~20.0 mo | ~53.0 mo | ~21 | ~R 567 284 PFS proxy · indirect | 8 |
Bosutinib monotherapy Variant #01 Partial | — | — | 28d | — | — | — | — | — |
3 of 3 regimens shown